Biorep Technologies

Biorep Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2M

Overview

Biorep Technologies is a specialized medical device CDMO with over 30 years of experience, offering integrated services from prototyping to commercial-scale manufacturing. The company's value proposition centers on deep domain expertise in regulated devices, a vertically integrated operational model, and flexible partnership structures that reduce vendor complexity for clients. Its ISO 13485-certified and FDA-registered infrastructure is designed to mitigate regulatory risk and streamline time-to-market for innovators in cardiovascular, surgical, ENT, and other therapeutic areas.

CardiovascularSurgicalENT

Technology Platform

Vertically integrated medical device CDMO platform encompassing rapid prototyping, design for manufacturability (DFM), process development, ISO 13485-certified contract manufacturing, and complex assembly services under a unified quality management system.

Funding History

1
Total raised:$2M
Seed$2M

Opportunities

The growing trend of outsourcing in med-tech and the desire to reduce vendor complexity present a significant opportunity for Biorep's integrated, end-to-end CDMO model.
Expansion into adjacent high-growth therapeutic areas and scaling services for global clients can drive further growth.

Risk Factors

Key risks include client concentration, operational execution failures that could damage its regulatory reputation, and intense competition in the CDMO space which may pressure pricing and margins.

Competitive Landscape

Biorep competes in a fragmented but competitive market of medical device contract manufacturers and CDMOs. Its primary differentiators are its exclusive focus on medical devices (not pharma), vertically integrated services, and over 30 years of specialized experience in navigating FDA and global regulatory pathways.